Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001628280-26-017302
Filing Date
2026-03-12
Accepted
2026-03-12 16:34:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A elicio-sx3a2.htm S-3/A 354926
2 EX-23.1 exhibit231-sx3a2.htm EX-23.1 2465
3 image_0a.jpg GRAPHIC 26290
  Complete submission text file 0001628280-26-017302.txt   394808
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-293861 | Film No.: 26748369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)